Yüklüyor......
Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Abstract. Endothelin receptor antagonists (ERAs) have been shown to improve the prognosis of patients with pulmonary arterial hypertension (PAH). However, the effect of the oral dual ERA bosentan on peripheral endothelial dysfunction (PED), as assessed by flow-mediated vasodilation (FMD), in patient...
Kaydedildi:
| Yayımlandı: | Pulm Circ |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
University of Chicago Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869920/ https://ncbi.nlm.nih.gov/pubmed/27252842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685715 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|